Rothschild & Co Asset Management US’s Biogen BIIB Stock Holding History

Rothschild & Co Asset Management US’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-30,925	Closed	-$8.27M	–	302
2020 Q2	$8.27M	Sell	30,925 -47,639	-61%	-$14.3M	0.12%	231
2020 Q1	$24.9M	Sell	78,564 -34,019	-30%	-$10.3M	0.39%	93
2019 Q4	$33.4M	Sell	112,583 -43,249	-28%	-$12M	0.35%	117
2019 Q3	$36.3M	Buy	155,832 +10,041	+7%	+$2.34M	0.39%	99
2019 Q2	$34.1M	Sell	145,791 -10,876	-7%	-$2.51M	0.36%	112
2019 Q1	$37M	Sell	156,667 -1,848	-1%	-$582K	0.4%	91
2018 Q4	$47.7M	Sell	158,515 -847	-0.5%	-$270K	0.58%	39
2018 Q3	$56.3M	Buy	159,362 +3,478	+2%	+$1.2M	0.58%	37
2018 Q2	$45.2M	Buy	155,884 +363	+0.2%	+$102K	0.49%	54
2018 Q1	$42.6M	Buy	155,521 +35,039	+29%	+$10.9M	0.47%	60
2017 Q4	$38.4M	Sell	120,482 -23,057	-16%	-$7.4M	0.41%	87
2017 Q3	$44.9M	Buy	143,539 +79,334	+124%	+$23.5M	0.49%	59
2017 Q2	$17.4M	Sell	64,205 -4,168	-6%	-$1.1M	0.2%	196
2017 Q1	$18.7M	Sell	68,373 -1,542	-2%	-$436K	0.21%	187
2016 Q4	$19.8M	Buy	69,915 +3,697	+6%	+$1.1M	0.25%	158
2016 Q3	$20.7M	Sell	66,218 -48,443	-42%	-$14.3M	0.36%	97
2016 Q2	$27.7M	Sell	114,661 -14,741	-11%	-$3.88M	0.5%	47
2016 Q1	$33.7M	Buy	129,402 +277	+0.2%	+$73.2K	0.63%	41
2015 Q4	$39.6M	Buy	129,125 +72,843	+129%	+$20.9M	0.72%	31
2015 Q3	$16.4M	Buy	56,282 +1,382	+3%	+$456K	0.32%	105
2015 Q2	$22.2M	Buy	54,900 +216	+0.4%	+$86.7K	0.41%	70
2015 Q1	$23.1M	Buy	54,684 +9,128	+20%	+$3.6M	0.44%	69
2014 Q4	$15.5M	Buy	45,556 +606	+1%	+$196K	0.31%	105
2014 Q3	$14.9M	Buy	44,950 +39	+0.1%	+$12.9K	0.32%	93
2014 Q2	$14.2M	Buy	44,911 +1,544	+4%	+$465K	0.29%	104
2014 Q1	$13.3M	Sell	43,367 -26,971	-38%	-$8.56M	0.3%	107
2013 Q4	$19.7M	Sell	70,338 -1,001	-1%	-$259K	0.44%	60
2013 Q3	$17.2M	Sell	71,339 -4,638	-6%	-$1.04M	0.37%	81
2013 Q2	$16.4M	Buy	+75,977	New	+$16.2M	0.38%	73